Poster Number |
Proposal Name |
First Name |
Last name |
Day 1 |
|
|
|
ASD 1 |
Streamlining the genetics pipeline to increase testing for patients at risk for hereditary prostate cancer: the UCSF Prostate Cancer Genetic Testing Station. |
Fern |
Alagala |
ASD 2 |
COVID workflow adjustments impact where, when, and how genetic counseling was delivered early in the pandemic |
Cary |
Armstrong |
ASD 3 |
Family History Collection, Genetic Risk Assessment, and Use of Digital Health Tools by Obstetricians |
Hitashi |
Bansal |
ASD 4 |
Utilization of Genetics Services in the Diagnosis of Hearing Loss in Newborns in the State of Ohio |
Cara |
Barnett |
ASD 5 |
Genomic Testing in Healthy Individuals: The Brigham Preventive Genomics Clinic |
Tala |
Berro |
ASD 6 |
"It's the same as if you did meet them in person" The Genetic Patient's Perspective on Telehealth Consultations |
Emily |
Bonnell |
ASD 7 |
One Cancer Genetic Counseling Clinic’s Response to COVID-19: ‘Ghost Protocol’ |
Christine |
Bruha Steele |
ASD 8 |
Evaluation of Family Group Telehealth Genetic Counseling Services |
Natasha |
Chadburn |
ASD 9 |
Genetic counseling in the inpatient care setting: genetic counselors perceive that on-demand services are valuable to patients and providers |
Cheyla |
Clark |
ASD 10 |
Integration of universal genetic counseling and testing for newly diagnosed breast cancer patients |
Julie O. |
Culver |
ASD 11 |
Genetic Counselor Perceptions of Patient Outcomes from Non-Genetics Providers Offering Genetic Services |
Katharine |
Drum |
ASD 12 |
Implementation and Evaluation of a Genetic Services Referral Phone Line in the New York-Mid-Atlantic Consortium (NYMAC) Region |
Alyson E. |
Evans, MS |
ASD 13 |
How Much We Tell Our Patients: Counseling Differences between Genetic Counselors and Other Providers |
Jessica |
Feldman |
ASD 14 |
Patient satisfaction with direct telegenetic counseling for prenatal compared to hereditary cancer indications |
Kristi |
Fissell |
ASD 15 |
Perceptions of Genetic Counseling and Testing in the Haitian Patient Population |
Elizabeth |
Francisco |
ASD 16 |
Delivering Bad News in Genetic Counseling via Telephone: Evaluating Distress, Perceived Personal Control, and Satisfaction in Patients |
Allison |
Gossen |
ASD 17 |
“You’re in charge of your health”: Perspectives of hereditary cancer population screening participants |
Veronica |
Greve |
ASD 18 |
Comparing Clinician-Parent Communication Patterns During Genome Sequencing Result Disclosures in a NICU Setting |
Brittany |
Griffin |
ASD 19 |
Satisfaction with online pre-test education, at-home BRCA screening, and telehealth genetic counseling in the Ashkenazi Jewish population: an Atlanta pilot study |
Melanie W. |
Hardy, MS, MS, CGC |
ASD 20 |
Assessment of Understanding and Satisfaction of Clinical Exome Sequencing (ES): Video Consent vs Telephone Consent |
Hannah |
Helber |
ASD 21 |
A Novel Genetic Testing Reminder System Using an Online Signature Platform |
Sayoni |
Lahiri |
ASD 22 |
Extending the Reach of Cancer Genetic Counseling to the Safety Net: Effectiveness of Genetic Counseling across Three Modes of Delivery |
Robin |
Lee |
ASD 23 |
Characterization of Genetic Counselor Practices in Inpatient Care Settings |
Emily |
Magness |
ASD 24 |
The Innovative Use of RedCap as a Means to Recontact Patients with Hereditary Cancer |
Caitlin |
Mauer |
ASD 25 |
Telegenetics vs. In-Person Satellite Clinic- Patient acceptance and effect on access and adherence |
Ryan |
Noss |
ASD 26 |
Exploring South Asian Perspectives on Genetic Counseling |
Shabri |
Patel |
ASD 27 |
SHAPING A DIALOGUE: INSIGHTS FROM THE SICKLE CELL COMMUNITY ON GENETICS HEALTHCARE |
Diana |
Phan |
ASD 28 |
Patient satisfaction with Genetic Results Counseling service |
Ellen |
Schlenker |
ASD 29 |
Characterization of genetic counseling follow-up decisions among patients with a medically actionable result from genomic screening |
Marci |
Schwartz |
ASD 30 |
Exploring perceptions and attitudes towards integrating a genetic counselor into a multidisciplinary primary care practice team. A qualitative GenCOUNSEL study |
Caitlin |
Slomp |
ASD 31 |
Genetic counselors leveraging technology: Integrating telemedicine into general genetics clinic via pre-clinic screening |
Christine |
Spaeth |
ASD 32 |
Inherited Retinal Degeneration Current Genetics Practices – A Needs Assessment |
Sydney |
Strait |
ASD 33 |
Custom automated software tools increase genetic counseling follow-up task efficiency |
Kelly |
Tangney |
ASD 34 |
Adapting Genetic Testing Results Disclosures to Patient Preferences at the Prostate Cancer Genetic Testing Station |
Barry |
Tong |
ASD 35 |
Should All Patients with Breast Cancer be Offered Genetic Testing? Reactions to the ASBrS Consensus Guideline on Genetic Testing for Hereditary Breast Cancer |
Kelly |
Tripi |
ASD 36 |
Impact of a GCA on genetic counselor efficiency in a cancer genetics clinic |
Meghan |
Vanwanzeele |
ASD 37 |
How Do Genetic Counselors and Genetic Counseling Assistants Spend Their Time? A Workflow Analysis |
Siddika |
Venkatachalam |
ASD 38 |
Barriers Remaining After the Integration of Genetic Counseling in a Multi-Disciplinary Pancreatic Cancer Clinic |
Elise |
Watson |
ASD 39 |
A Snapshot of Consumer-Initiated Genetic Testing: A Demographic Chart Review |
Nori |
Williams |
ASD 40 |
Motivations For Ordering Consumer-Initiated Genetic Testing: A Chart Review |
Nori |
Williams, CGC |
ASD 41 |
Refining a Tool to Automate Portions of Pre-Test Genetic Counseling for Inherited Cancer |
Brenda |
Zuniga |
ADT 42 |
Familial Partial Lipodystrophy Type 2 and 3 due to Likely Pathogenic LMNA and PPARG Variants Identified in Two Individuals with Atypical Presentations |
Colby |
Chase |
ADT 43 |
DTC Ancestry Testing Reveals a 46,XX Male and Infertility |
Kelly |
East |
ADT 44 |
Identification of a pathogenic MECP2 variant in two adults presenting to a Medical Genetics clinic with intellectual disability |
Anna |
Raper, MS, CGC |
ADT 45 |
The Perspective of Men with Barth Syndrome: Relationship Building, Family Planning, and Reproductive Decision-Making |
Jason |
Shandler |
ADT 46 |
eMERGE Consortium Participant Reported Sharing of Genomic Screening Results with Family Members. |
Julia |
Wynn |
CAN 47 |
CTNNA1 Reclassified From Pathogenic To a Variant of Unknown Significance In a Breast Cancer Patient: Managing Patient and Counselor Expectations |
Dina |
Alaeddin |
CAN 48 |
Somatic Tumor Testing Implications for Lynch Syndrome Germline Genetic Testing |
Kathleen |
Barrus |
CAN 49 |
Breast cancer in PMS2-positive patients |
Kylin |
Boehler |
CAN 50 |
Positive Patient BRCA1/2 Direct-to-Consumer Genetic Testing Results: Now What? |
Sarah |
Burke |
CAN 51 |
Case of BRCA Double Heterozygosity in a Non-Ashkenazi Jewish Individual |
Cara |
Cacioppo |
CAN 52 |
Utilization of broad approaches of genetic counseling and testing to better understand pediatric cancer predisposition |
Katie |
Church |
CAN 53 |
Risk Reducing Mastectomies among Women with Mutations in Moderate Penetrance Breast Cancer Susceptibility Genes |
Jacob |
Comeaux |
CAN 54 |
Reported Phenotype in Individuals with NF1 Pathogenic Variants Identified by Panel Testing |
Lauren |
Currie |
CAN 55 |
Trends in Ordering Patterns of Hereditary Cancer Panels |
Lauren |
Currie |
CAN 56 |
A novel case of lobular breast cancer in a male patient with a pathogenic mutation in CDH1 |
Matthew |
Emery |
CAN 57 |
Co-occurrence of attenuated familial adenomatous polyposis (AFAP) and Lynch syndrome: A case report with implications for surveillance. |
Jamie |
Fisher |
CAN 58 |
Genetic counselors’ use of multi-gene panels in cancer genetics: A quantitative study |
Natasha |
Fuller |
CAN 59 |
Expanding Phenotypes for Male BARD1 Carriers: A Case Report |
Melissa |
Gandhi |
CAN 60 |
Discrepant CDKN2A c.146T>C variant: a clinical experience |
Amber |
Gemmell |
CAN 61 |
Motivations for Pursuing Genetic Counseling to Explore the Availability of Panel Genetic Testing |
Jessalyn |
Gerber |
CAN 62 |
Toward a Better Understanding of the Experience of Patients with Moderate Penetrance Breast Cancer Gene Mutations: A focus on ATM and CHEK2 |
Carly |
Grant |
CAN 63 |
Who would have been missed? A comparison of current and past hereditary cancer testing guidelines in a large prospective universal testing study |
Megan |
Hager |
CAN 64 |
Pathogenic variant classifications are not always well-supported by evidence |
Sarah M. |
Hamilton |
CAN 65 |
An Extended Case Series of Gastrointestinal Neoplasms in Li-Fraumeni Syndrome |
Jessica |
Hatton |
CAN 66 |
Families with Rare POT1 Variants Identified Through Multigene Panel Testing |
Marie-Louise |
Henry |
CAN 67 |
Implementation of Hereditary Genetic Testing for All Patients with a Personal History of Breast Cancer: Perspectives of Key Healthcare Professionals |
Kyle |
Heraty |
CAN 68 |
Melanoma Risk in POT1 Mutation Carriers from a MGPT Cohort |
Jennifer |
Herrera-mullar |
CAN 69 |
Site-Specific Analysis vs. Multi-Gene Panel Testing for Familial Cancer Variants: Current Practices of Genetic Counselors |
Eleanor |
Hilton |
CAN 70 |
Review Process of Somatic Tumor Reports for Genetic Counseling Referrals |
Brenda |
Ho |
CAN 71 |
De novo TP53 variant in a child with early onset rhabdomyosarcoma and maternal history of gestational choriocarcinoma |
Sarah E |
Jennings |
CAN 72 |
Attitudes and Practices of Genetic Counselors towards Hereditary Cancer Syndromes with Associations of Unclear or Conflicting Evidence |
Kerry |
Johnson |
CAN 73 |
Evaluation of Pilot Program to Implement Breast Cancer Risk Assessment at Screening Mammography in One US Health System |
Alanna |
Kulchak Rahm |
CAN 74 |
Expanding the detection range of DNA multigene panel testing with concurrent RNA sequencing |
Holly |
LaDuca |
CAN 75 |
An Interpretative Phenomenological Analysis: The Lived Experience of Emerging Adults at Risk for Gastric Cancer Due to a CDH1 Variant in Medical Management Decision Making |
Yi |
Liu |
CAN 76 |
Real-world Multi-Country Study of Germline BRCA1/2 Mutation (gBRCA1/2mut) Testing and Genetic Counseling (GC) Among Patients (pts) With Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced Breast Cancer (ABC) |
Reshma |
Mahtani |
CAN 77 |
Inconclusive genetic test results and a phenotype possibly confounded by prior childhood cancer |
Rachelle |
Manookian |
CAN 78 |
Double heterozygosity for RET and PTEN: one family’s phenotype |
Nicole |
Mans |
CAN 79 |
A case report of an incidental germline AXIN2 likely pathogenic variant in a patient with ovarian cancer |
Kimberly |
Matthijssen |
CAN 80 |
Development and Initial Outcomes of a Hereditary Hematologic Malignancies Clinic |
Kelsey |
Moriarty |
CAN 81 |
A case of an infant with Beckwith Wiedemann syndrome and Marfan syndrome: The value of taking a family history |
Alise |
Murray |
CAN 82 |
An unexpected diagnosis of MUTYH-associated polyposis: A case study |
Honey |
Nagakura |
CAN 83 |
Comprehensive germline multigene panels change clinical care and inform treatment strategies for breast cancer patients |
Sarah M |
Nielsen |
CAN 84 |
Genetic Counselors’ Attitudes and Practices Regarding Preimplantation Genetic Testing for Hereditary Breast and Ovarian Cancer |
Hannah |
Novak |
CAN 85 |
Sources of Community Referrals to a Pediatric Cancer Predisposition Clinic: Opportunities for Outreach |
Regina |
Nuccio, MS, CGC |
CAN 86 |
IMPLEMENTING BRCA MAINSTREAMING IN AUSTRALIA: A QUALITATIVE STUDY |
Rosie |
O Shea |
CAN 87 |
Genetic Counseling (GC) Patterns by Practice Setting Among Patients (pts) With Germline BRCA1/2 Mutated (gBRCA1/2mut) Advanced Breast Cancer (ABC): Results From a US Retrospective Medical Records Review Study |
Elias |
Obeid |
CAN 88 |
A Process Improvement Analysis of Referral Rates to Genetic Counseling for Consideration of Germline Genetic Testing After Receipt of Somatic Genetic Testing Results |
Rachel |
Paul |
CAN 89 |
BRIP1: An institutional experience with a dynamic gene |
Sara |
Pirzadeh-Miller |
CAN 90 |
“I wish that there was more info”: Characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants |
Kathryn |
Reyes |
CAN 91 |
Exploring Current Practices and Perspectives of Genetic Counselors on DNA Biobanking in Oncology |
Hillary |
Rieger |
CAN 92 |
A Qualitative Study of Transgender Patients’ Perspectives on their Cancer Genetic Counseling Experiences |
Lathel |
Rolle |
CAN 93 |
Impact of Genetic Based Melanoma Risk Assessment on Attitudes and Preventative Behaviors |
Kaylee |
Ruiz |
CAN 94 |
An Analysis of the Lived Experience of Patients Incidentally Found to Carry a Pathogenic TP53 Mutation |
Emily |
Seckington |
CAN 95 |
Rapid Adaptation and Evaluation of a Telemedicine-Only Cancer Genetic Counseling Model in the COVID-19 Pandemic |
Margaret |
Sheehan |
CAN 96 |
A Postmortem End to the Diagnostic Odyssey: The Diagnosis of Noonan Syndrome in a Boy with ALL and Secondary T-Lymphoblastic Lymphoma |
Susan |
Shehayeb |
CAN 97 |
Psychosocial Outcomes Following An Abnormal ctDNA-Based Cancer Screening Test |
Gabrielle T. |
Shermanski, MS |
CAN 98 |
Provider Experiences with Incidental Germline Findings Revealed Through Somatic Sequencing in Oncology |
Ilana |
Solomon |
CAN 99 |
The Impact of the “American Society of Breast Surgeon’s 2019 Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer” on Cancer Genetic Counselors |
Jillian |
Tokarczyk |
CAN 100 |
Germline pathogenic/likely pathogenic variant incidence in individuals with colorectal cancer stratified by age at diagnosis |
Natalie |
Tri |
CAN 101 |
Atypical genetic causes of Lynch syndrome: a case series |
Magan |
Trottier |
CAN 102 |
Frequency of 5 Cancer Types in Families with a Pathogenic or Likely Pathogenic Variant in the ATM Gene |
Diana Moglia |
Tully |
CAN 103 |
Mosaic STK11 Mutation in the Context of a Clinical Diagnosis of Peutz-Jeghers Syndrome (PJS) and Ashkenazi Jewish Ancestry: Genetic Counseling Opportunities and Challenges |
Morgan |
Turner, MS, CGC |
CAN 104 |
Clinical Presentation of Individuals with Pathogenic/Likely Pathogenic TP53 Variants Detected via Different Ascertainment Methods: a Case Series |
Julia |
Weston |
CAN 105 |
Factors in Screen Adherence Across the Lifespan in Individuals with Rare Hereditary Cancer Syndromes |
Amy |
Whitburn |
CAN 106 |
The Phenotype of POT1 Pathogenic Variant Carriers |
Elizabeth |
Wiley |
CAN 107 |
Early-onset triple negative breast cancer for a family with a likely pathogenic RAD51C mutation: considerations for improved screening and surveillance |
Edward |
Williams |
CAN 108 |
From Business Plan to a Three-Year Implementation Review: Successes/Challenges for the solo genetic counseling establishing hereditary cancer risk assessment and risk education |
Edward |
Williams |
CAN 109 |
A pilot study of breast cancer polygenic risk scores shows discrepancies between laboratories. |
Julia |
Wynn |
CAN 110 |
Neuroblastoma and Cutaneous Angiosarcoma in a Child with PTEN Hamartoma Tumor Syndrome |
Kristin |
Zelley |
CAN 111 |
Evaluation of Genetic Counseling Referral Rates Before and After Inclusion of Genetic Counselor Attendance at Gynecologic Oncology Tumor Board |
Marie |
Zerjav |
CAR 113 |
What Makes at-risk Family Members Pursue Cascade Genetic Testing for Hypertrophic Cardiomyopathy? |
Emily |
Callahan |
CAR 114 |
Development of Death Investigator Education on Genetics and Postmortem Genetic Testing - A Pilot Study |
Rachel |
Campagna |
CAR 115 |
Risk perception and screening behaviors in individuals with an inherited predisposition for Hypertrophic Cardiomyopathy |
Melanie |
Emmerson |
CAR 116 |
Exploring the Communication of Cardiac-Related Risk to First-Degree Relatives After the Sudden Death of a Young Family Member |
Martha |
Francoeur |
CAR 117 |
Genetic counseling for bicuspid aortic valve: Predictors of knowledge, empowerment, and familial uptake of cardiac screening |
Bailey |
Hancock |
CAR 118 |
Comprehensive Analysis of Cardiomyopathy and Arrhythmia Genes Yields Unanticipated Molecular Diagnoses |
Ana |
Morales |
CAR 119 |
Exploring Lab vs. Clinical Discrepancies in Five Genes Known to Cause Loeys-Dietz Syndrome |
Mitchel |
Pariani |
CAR 120 |
Investigating Medical Examiners’ Practices: Genetic Evaluation for Fatal Acute Aortic Dissection |
Bradley |
Power |
CAR 121 |
Pediatric Primary Care Providers Use of And Adherence to Cholesterol Screening Guidelines When Assessing Patients For Hypercholesterolemia: A Qualitative Assessment of Providers In Minnesota And California |
Jenna |
Soukup |
CAR 122 |
Applying Motivational Interviewing Strategies with the Extended Parallel Process Model to Improve Risk Communication for Parents of Children with Familial Hypercholesterolemia |
Bridget |
Winchester |
CAR 123 |
Outcomes from a Novel Genetic Counseling Intervention Using Motivational Interviewing and The Extended Parallel Process Model to Increase Cascade Cholesterol Screening |
Heather |
Zierhut |
CPI 124 |
Exploration of Patient Attitudes toward Receiving Incidental Diagnoses of Lysosomal Storage Disorders Through Expanded Carrier Screening |
Allison |
Abbott |
CPI 125 |
Getting punched in the gut – The experience of families receiving a negative genome-wide sequencing result |
Shelin |
Adam, MSc |
CPI 126 |
The Impact of Hindu Philosophy on Perspectives of Hindu Women on Pregnancy Termination |
Amanda |
Back |
CPI 127 |
Depression Screening Practices of Prenatal Genetic Counselors |
Sarah |
Belsky |
CPI 128 |
Time well spent: Lessons learned from a qualitative study exploring parental reactions to genetic counseling patient letters after a pediatric visit |
Courtney |
Brown |
CPI 129 |
Decision-Making in Mental Health Referral: The Influence of Genetic Counselor Emotion |
Hannah |
Campbell |
CPI 130 |
Discordant Interpretations of Germline Variants in Hereditary Cancer - A Psychosocial Burden? |
Meera |
Clytone |
CPI 131 |
Simpatía y Respeto: Spanish speaking genetic counselors’ perceptions of language concordance in genetic counseling sessions |
Amanda |
de Leon |
CPI 132 |
Proxy Patient's Perceptions of Genetic Counselor's Empathy Responses |
Jennine |
Deckert |
CPI 133 |
Calculating and Communicating Error Estimates For Pathogenic Variant Classifications |
Julie M. |
Eggington |
CPI 134 |
An Exploration of the Psychosocial Impact of Gene Therapy for Individuals with Hemophilia |
Haley |
Fischman |
CPI 135 |
Experiences and Perspectives of Patients who Have Considered or Undergone Transfer of Embryos with Mosaic PGT-A Results |
Eva |
Gabor-Fourcade |
CPI 136 |
Genetic counselors' practices and perceptions when counseling native clients |
Hannah |
Garn |
CPI 137 |
Investigating factors that influence genetic counselors’ decisions to refer patients to mental health providers |
Taylor |
Hayes |
CPI 138 |
Use of NCCN Distress Thermometer in Cancer Genetics Patients |
Michelle F. |
Jacobs |
CPI 139 |
Hispanic Patients’ Perspectives on Language-Concordant Cancer Genetic Counseling Sessions |
Sharisse |
Jimenez |
CPI 140 |
Characterizing the Mental Health Referral Process in Genetic Counseling |
Colleen |
Jodarski |
CPI 141 |
Are genetic counselors prepared to counsel active-duty service members? |
Michael |
Kamen |
CPI 142 |
Review of patients who actively decline recommended CIT post-test genetic counseling |
Robin |
King |
CPI 143 |
Psychological Distress in Response to Physical Activity Restrictions in Patients with Non-syndromic Thoracic Aortic Aneurysm/Dissection |
Alexis |
McEntire |
CPI 144 |
Exploring the impact of empathy-based practice on a genetic counselor’s emotional state during their pregnancy |
Emma |
Moores |
CPI 145 |
From bookbags to company cars: A window into the experiences of growing up with an undiagnosed medical condition |
Christina |
Pool |
CPI 146 |
The Psychosocial Impact of Having a Child with Usher Syndrome: What Can be Done to Better Meet the Needs of Parents and Caregivers |
Rachel |
Rabenn |
CPI 147 |
Issues of countertransference in providing reproductive genetic counseling for a patient with SMA type II |
Jill |
Slamon |
CPI 148 |
Genetic Testing and Counseling for Asian Americans: A Systematic Review |
Jennifer |
Young |
EDU 149 |
Graduate Training Experiences of Genetic Counseling Students in the United States and Canada |
Pauline |
Aamodt |
EDU 150 |
Genetic Counseling Graduate Programs: Is a Standardized Application Possible? |
Erin |
Beasley, BA |
EDU 151 |
Bayes for Days: Development of a Case-Based Risk Assessment Course for Genetic Counselors |
Grace |
Bronken, MS |
EDU 152 |
Genetics Knowledge of Patients with Hereditary TTR Amyloidosis |
Emily |
Brown |
EDU 153 |
Group Meditation, Addressing Stigma, and ‘Mental Health Days’: Recommendations for Integrating Self-Awareness Practices into Genetic Counseling Graduate Programs |
Laura |
Bulmer, MS |
EDU 154 |
Impact of Medical Improv Training on Preparation Genetic Counseling Assistants for Graduate School Interviews |
Remington |
Fenter |
EDU 155 |
Exploring the Impact of a Variant Curation Module in the Undergraduate Classroom |
Kassandra |
Grimm |
EDU 156 |
Creating and Evaluating a Tool to Support Families Receiving Genomic Testing Results |
Julia |
Handra |
EDU 157 |
Two Cycles In: Investigating Admissions Committee Members’ Perspective on the Genetic Counseling Match |
Eileen |
Hoffman |
EDU 158 |
Genetic Counseling Assistant-Run Clinic: Enhancing Prospective Genetic Counselors’ Skill Sets and Improving Clinic Efficiencies |
Caitlin |
Mauer |
EDU 159 |
Digital peer-to-peer sharing: Online opportunities for NBS education |
Brianne |
Miller |
EDU 160 |
Podcast Development to Train Genetic Counseling Clinical Supervisors: A Pilot Study |
Rebecca |
Padersky |
EDU 161 |
Exploring Genetic Counseling Students' Experiences with the Job Search and the Impact of Clinical Training |
Haewon |
Park |
EDU 162 |
Development of a Graduate Certificate in Genomics for Genetic Counselors at UBC |
Anastasia |
Richardson |
EDU 163 |
Assessing the training of current genetic counseling students related to pharmacogenomic testing |
Daniel |
Serber |
EDU 164 |
Are Genetic Counseling Graduates Prepared to Counsel on Health Insurance Coverage and Costs of Genetic Testing? |
Hannah |
Sigurdson |
EDU 165 |
Anger, Fear, and Sadness: Differences in Genetic Counseling Student Responses to Intense Patient Affect |
Rachel |
Simon |
EDU 166 |
Assessing the Current State of Affairs Surrounding Education on Counseling Direct-to-Consumer Testing Patients Through Surveying Genetic Counseling Program Directors |
Erin |
Swartz |
EDU 167 |
Pharmacogenetics and Direct-to-Consumer Testing: A Knowledge Gap in the Genetic Counseling Community |
Alora |
Terry, MS, GC |
EDU 168 |
The Development of a Telehealth Rotation in Response to Program Needs |
Shannon |
Wieloch |
EDU 169 |
Genetic Counseling Student Remote Rotation in ClinGen Variant Interpretation: Expanding Training Options |
Diane |
Zastrow |
ELS 170 |
Defining the Critical Components of Informed Consent for Genetic Testing |
Maia |
Borensztein |
ELS 171 |
Increasing recruitment of patients with undiagnosed diseases from underserved populations in the Pacific Northwest |
Brenna |
Boyd |
ELS 172 |
Impact of Psychiatric Genetic Data on Tort Litigation and its Relationship with Stigma |
Kira |
Dineen, MS, GC, CG(ASCP)CM |
ELS 173 |
Understanding genetic counselors' perceptions of a duty to warn |
Alexis |
Lash |
ELS 174 |
Impact of ancestry-related test limitations on informed consent and pre-test genetic counseling |
Joseph |
Liu |
ELS 175 |
Ethical Considerations for X-ALD Screen-Positive Females on State Newborn Screening |
Claire |
Newman, MS, CGC |
ELS 176 |
The Role of GenomeConnect in Keeping Patients Updated about their Genetic Test Results |
Juliann M. |
Savatt |
ELS 177 |
A Family Dilemma: Ethical Considerations While Coordinating Familial Testing for an Inherited Telomere Biology Disorder |
Lindsey |
Schmidt |
ELS 178 |
Genetic Counseling Students and Recent Graduates’ Opinions about Abortion |
Courtney |
Schuiteman |
ELS 179 |
Knowledge and Attitudes About Privacy and Secondary Data Use Among African Americans Consumers Using Direct-to-Consumer Genetic Testing |
Emily |
Ziegler |
Day 2 |
|
|
|
GGT 180 |
Post Mortem Genetic Testing in Sudden Unexpected Death in Epilepsy [SUDEP]: A Pilot Study |
Yu |
An |
GGT 181 |
Clinically Actionable Findings Derived from Predictive Genomic Testing Offered in a Medical Practice Setting |
Jennifer |
Anderson, MS, LCGC |
GGT 182 |
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in the United States |
Ramesh |
Arjunji |
GGT 183 |
Mitochondrial Replacement Therapy: Genetic Counselors’ Experiences, Knowledge and Opinions |
Anjali |
Aryamvally |
GGT 184 |
The Role of Genetic Counseling Self-Efficacy in Variant Interpretation Discrepancies |
Brenna |
Bentley |
GGT 185 |
Preimplantation Genetic Testing: Indications for use and characteristics of users over 8 years at a single institution |
Megan |
Bunnell, MD, MS GCG |
GGT 186 |
Improving Exome Sequencing Diagnostic Rate by Investigation of Unsolved Cases |
Caitlin |
Chisholm |
GGT 187 |
Tools for Genetic Counseling Sessions with Direct to Consumer Genetic Testing Clients |
Allison |
Costa, BS, BA |
GGT 188 |
Adopted Individuals’ Interest in Elective Genomic Testing |
Jessica |
Edgar |
GGT 189 |
Making somatic less enigmatic: A survey of genetic counselors working in the somatic arena |
Dana |
Farengo-Clark |
GGT 190 |
Utility of Adding Phenotypic Criteria Refinement to ACMG Guidelines |
Lauren |
Frank |
GGT 191 |
The Potential Incorporation of Pharmacogenetic Testing into the Genetic Counseling Practice |
Zoey |
Freedman |
GGT 192 |
A method to improve genetic diagnostic yield among patients suspected to have primary immunodeficiency |
Kim |
Gall |
GGT 193 |
Genetic Counselors’ Decision-Making in the Utilization of Polygenic Risk Scores in Breast Cancer Clinical Care |
Rachel |
Gosselin |
GGT 194 |
Participant Outcomes Following Return of Unanticipated Medically Actionable Findings |
Melissa |
Heller |
GGT 195 |
Genome Sequencing and the Challenges of the Rare Diagnosis in the NICU Setting |
Laura |
Hendon |
GGT 196 |
The Use of Functional Study in Investigating Variants of Uncertain Significance |
Jada |
Jackson |
GGT 197 |
An evidence-based evaluation of guidelines criteria for condition inclusion on ECS panels: identifying a guidelines-compliant panel |
Katie |
Johansen Taber |
GGT 198 |
Performance of a targeted cell-free DNA prenatal test for 22q11.2 deletions in a large clinical cohort |
Katheryn |
Jones |
GGT 199 |
Experiences and Preferences of the Amish and Mennonite Regarding Genetic Testing |
Torey |
Jordan |
GGT 200 |
Correlation of Reported Family History and Identified Genomic Results in a State-Funded Population Screening Research Initiative |
Whitley V. |
Kelley |
GGT 201 |
Two novel cases of biallelic variants in TARS2 presenting with hypotonia, psychomotor delay, cerebellar atrophy and microcephaly; Further evidence towards classification for a mitochondrial disease gene |
Megan |
Landsverk |
GGT 202 |
Parental Impressions of Genetic Services for Individuals with Treacher Collins Syndrome |
Paige |
Ledford |
GGT 203 |
Assessing Patient Attitudes Toward Pharmacogenetic Testing |
Grace |
Lee |
GGT 204 |
Patient satisfaction with consumer-initiated pharmacogenetic testing and post-test telehealth genetic counseling. |
Jacquelyn |
Magner |
GGT 205 |
Provider Thoughts and Opinions Towards Expanded Carrier Screening |
Derek |
Mann |
GGT 206 |
Parental testing plays a significant role in clarification of uncertain genetic test results in the pediatric setting. |
Kati |
Mason, MS, CGC |
GGT 207 |
Evaluating the Feasibility and Impact of Actively Requesting Clinical History at a Specialty Genetics Reference Laboratory |
Jamie |
McCreery |
GGT 208 |
Genetic Counselors' Experiences and Current Practices Utilizing Clinically Available Breast Cancer Polygenic Risk Scores |
Molly |
McGuinness |
GGT 209 |
Novel Screening for Advanced Paternal Age using Non-invasive Prenatal Testing for Single-Gene Disorders |
Pooja |
Mohan |
GGT 210 |
Early Insights on Patient Engagement in a Bi-directional Network Informs Future Development of an Interactive Genome Management Platform |
Ana |
Morales |
GGT 211 |
The Role of Allele-Specific RNA Analysis in Hereditary Cancer Variant Classification |
Erin |
Mundt |
GGT 212 |
Carrier Screening for X-linked Conditions is Common Practice |
Dana |
Neitzel |
GGT 213 |
Elucidating the phenotypic variability associated with the polyT tract in CFTR |
Keith |
Nykamp |
GGT 214 |
Collaborative approach to clinical correlation and variant interpretation provides diagnosis for 2 brothers with KDM6A variant |
Emily H. |
Palen |
GGT 215 |
Clinical outcomes of rare chromosomal abnormalities detected by a whole-genome non-invasive prenatal screening assay |
Sarah |
Paolucci |
GGT 216 |
Creating a source of truth: The Sanford experience with centralizing genomic information in the medical record. |
Erin |
Royer |
GGT 217 |
Prenatal theoretical diagnostic yield of a rapid, targeted genetic panel designed for critically ill pediatric patients. |
Danuta |
Stachiw-Hietpas |
GGT 218 |
Molecular Testing for ADPKD in Pediatric and Adult Cohorts Reveals Increased Incidence of PKD1 Truncating Variants in the Pediatric Population |
Laura |
Sulmonte |
GGT 219 |
Genetic Characterization of Shwachman Diamond Syndrome |
Ashley S. |
Thompson |
GGT 220 |
Unblurring the ultrasound lines: 45% of infants with prenatal findings receive a reportable result on diagnostic exome sequencing |
Meghan |
Towne |
GGT 221 |
Clinical outcomes of preimplantation genetic testing for hereditary cancer predisposition syndromes: A systematic review |
Natalie |
Vriesen |
GGT 222 |
Detecting Novel SNVs and Indels in Alpha Thalassemia Carriers |
J. Sherry |
Wang |
PED 223 |
Long-Term Outcomes of Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) |
Faria |
Ahmed |
PED 224 |
Supplemental Newborn and Pediatric Screening: Insight into Consumers and Results |
Stephanie |
Ashley, MGC, CGC |
PED 225 |
A recurrent DMD deletion in boys referred to genetics for cognitive and neurobehavioral disorders |
Miriam |
Bunch |
PED 226 |
Exploring Mothers' Experiences with their Child's Diagnosis of Hypermobile Ehlers Danlos Syndrome |
Lauren |
DeMeyer |
PED 227 |
Development of a Children's Book on Infertility and Family Planning for Girls with Turner Syndrome |
Aimee |
Durrett, MS, GC |
PED 228 |
Parental Perceptions of Genetic Testing for Hearing Loss: Value and Impact |
Briana |
Feirstein |
PED 229 |
Step by step: Diagnosis of rare mesoaxial synostotic syndactyly with phalangeal reduction following cascade testing in the pediatric genetics clinic |
Leslie |
Granger |
PED 230 |
The Spectrum of Features in Males and Females with Mosaic 45,X +Y |
Lindsey |
Guzewicz |
PED 231 |
The Economics of Genetic Disease in a Level IV NICU: Diagnostic Approaches and Cost of Care |
Leanne |
Hagen |
PED 232 |
The Parental Perspective of Waiting for Pediatric Clinical Whole Exome Sequencing Results |
Stephanie |
Lucia |
PED 233 |
EXPERIENCES WITH AND KNOWLEDGE OF GENETICS IN FAMILIES AFFECTED BY CONGENITAL ADRENAL HYPERPLASIA: THE PARENT PERSPECTIVE |
Christine |
Macica |
PED 234 |
Ultra-rare Diagnoses Highlighting the Importance of Variant of Uncertain Significance Interpretation |
Kari |
Magnussen |
PED 235 |
Epistaxis and Telangiectasias: Hereditary Hemorrhagic Telangiectasia (HHT) compared to the General Population |
Jamie |
McDonald |
PED 236 |
Open Operculum in Association with 22q11.2 Deletion Syndrome: An Underreported Diagnostic Biomarker Possibly Linked with Delay in Emergence of Language |
Jessica |
Merberg, MS |
PED 237 |
Continuing a Search for a Diagnosis: Perspectives from Parents of Children with Undiagnosed Diseases |
Ilana |
Miller |
PED 238 |
Anxiety, depression, and uncertainty impact quality of life in parents of children with a positive X-linked adrenoleukodystrophy newborn screen |
Kayla |
Muirhead |
PED 239 |
An Unusual Presentation of Rubinstein-Taybi Syndrome: Genetic Counseling Challenges |
Megan |
Parker Fonville, MS, CGC |
PED 240 |
Pitt-Hopkins syndrome: consider in the differential diagnosis in pediatric patients with global developmental delays |
Chana |
Ratner |
PED 241 |
Expanding the Phenotype of Xia Gibbs Syndrome: A Case Report on Patient with a Novel ADHC1 Variant |
Kelly |
Roche |
PED 242 |
Pediatric genetic counseling: a practice analysis and perspectives from pediatric genetic counselors - a consortium study |
Alyssa |
Sherwood |
PED 243 |
Not alone anymore: parent and sibling experiences finding support with an ultra-rare diagnosis |
Kaitlin C. |
Smith |
PED 244 |
Quality of Life of Children with Spinal Muscular Atrophy: Parents' Perspectives in Light of New Treatments |
Analyssa |
Tallas |
PED 245 |
Novel Cranial Nerve VI Hypoplasia causing lateral rectus palsy with pathogenic variant in PPP1CB |
Kerry M |
White, MS, LCGC |
PED 246 |
Assessing Interest in Genetic Counseling for Patients with Immune Deficiencies |
Victoria |
Willingham |
PRE 247 |
Compound heterozygote for Tay Sachs and Sandhoff disease: implications for Tay Sachs carrier testing by enzyme analysis |
Alexandra |
Barbarese |
PRE 248 |
Factors that Impact Uptake of Carrier Screening in Males |
Wendi |
Betting |
PRE 249 |
Exploring Factors that Influence Reproductive Decision-Making in Duchenne Muscular Dystrophy Carriers |
Caroline |
Bong |
PRE 250 |
Parental Questions About Sex Chromosome Aneuploidies Regarding Sex, Gender, and Sexual Orientation in a Prenatal Setting |
Sarah |
Burzynski, MS |
PRE 251 |
The Impact of Genetic Counseling on Patient Uptake and Satisfaction of Preimplantation Genetic Testing |
Alexis |
Coates |
PRE 252 |
Enhancement of spinal muscular atrophy carrier screening with unique variants: to include or not to include? |
Linda |
Cheng |
PRE 253 |
Mosaic Trisomy 13 Detected by Cell-Free DNA: Important Counseling Considerations for a Variable Phenotype |
Nicole |
Choy |
PRE 254 |
Utilization of Expanded Carrier Screening by Reproductive Genetic Counselors |
Emily |
Collins |
PRE 255 |
The Impact of Abortion Laws on Prenatal Genetic Counseling: A Comparison Between States |
Casey |
Crawford, MS |
PRE 256 |
Non-Invasive Prenatal Screening Results Suggestive of Maternal Malignancy: The Genetic Counselor's Experience |
Taylor |
Durant |
PRE 257 |
Using invasive testing rates and pregnancy outcomes to guide genetic counseling for patients who receive a failed cell-free fetal DNA screening. |
Jennifer |
Dykeman |
PRE 258 |
Diagnostic testing trends after genome-wide cell-free DNA prenatal screening results |
Kimberly |
Fanelli |
PRE 259 |
Physician Opinions on Mosaicism in Preimplantation Genetic Screening and Genetic Counseling |
Irene |
Ford |
PRE 260 |
Knowledge, perceptions, and current trends in carrier screening among Orthodox Jewish young adults |
Yoheved |
Gerstein |
PRE 261 |
Challenges in genetic counseling for renal anomalies |
Ping |
Gong |
PRE 262 |
Exploring the benefits, limitations, and impacts of reproductive carrier screening and telehealth-based genetic counseling for individuals found to have an increased reproductive risk |
Melanie |
Hardy |
PRE 263 |
Experiences of prenatal genetic counselors with abortion regulations in Ohio |
Anne |
Heuerman |
PRE 264 |
Family Communication of Genetic Results Found on Expanded Carrier Screening |
Haley |
Hill, MS |
PRE 265 |
Cell free DNA screening for copy number variants secures a diagnosis of Wolf-Hirschhorn syndrome in a pregnancy with suspected anomalies |
Natalie |
Jacob |
PRE 266 |
Female and Male Perspectives on the Involvement of Male Partners in Expanded Carrier Screening |
Sarah |
Jurgensmeyer |
PRE 267 |
A Familial Xq Deletion/Duplication Ascertained Incidentally via Sequencing-Based Expanded Carrier Screening |
Olga |
Latosh |
PRE 268 |
Prenatal Diagnosis of Swyer Syndrome due to Discordance Between cfDNA and Fetal Ultrasound |
Enrique |
Lopez |
PRE 269 |
Reporting and Transfer of Mosaic Embryos: Experiences and Attitudes of Genetic Counselors |
Casey |
Marks |
PRE 270 |
Prenatal ascertainment of Bardet Biedl syndrome that was missed by expanded carrier screening |
Erin |
McGraw |
PRE 271 |
Pregnancy, Genetic Counseling and Cystic Fibrosis: Exploring the experiences and discussions between females with CF and their health care providers. |
Morgan |
McManus |
PRE 272 |
Assessing Social Media for Themes of Trisomy 18 and 13 |
Falecia |
Metcalf |
PRE 273 |
Omphalocele and monosomy X: expanding the phenotype of 45,X through first trimester ultrasound |
Kristen |
Miller |
PRE 274 |
EXPERIENCE WITH PREIMPLANTATION GENETIC TESTING FOR CONDITIONS THAT ARE FOUND TO BE DE NOVO IN CHILD |
Rachel |
Mnushkin |
PRE 275 |
Expanded Carrier Screening allowed Prenatal Diagnosis of Congenital Finnish Nephrosis without Diagnostic Testing |
Alexis |
Morgan |
PRE 276 |
Prenatal diagnosis of mosaic 45,X/46,X,idic(Y) after discordant findings from cell free DNA and prenatal ultrasound: A case series |
Lauren |
Petrarca |
PRE 277 |
The Emotional Impact of Restrictive Abortion Laws on Prenatal Genetic Counselors |
Elizabeth |
Pollard |
PRE 278 |
Genetic counseling on road to a complex familial diagnosis: A lethal ciliopathy. |
Nivedita |
Rajakumar |
PRE 279 |
Genetic counselors’ experiences with transgender individuals in prenatal and preconception settings |
Maggie |
Ruderman |
PRE 280 |
Diagnostic Testing Uptake Rates in Fragile X Premutation Carriers and Couples At Risk for an Autosomal Recessive Condition in Their Offspring |
Kendall |
Snyder |
PRE 281 |
“Desbu-what?”: Rare diagnosis highlights limitations of ultrasound parameters suggestive of lethal skeletal dysplasia |
Samantha |
Stover |
PRE 282 |
Prenatal Genetic Testing Decisions After In Vitro Fertilization with Preimplantation Genetic Testing |
Marina |
Sumarroca |
PRE 283 |
Patient Knowledge of, Attitudes Toward, and Perceived Utility of Carrier Screening in an Obstetric Setting |
Rachel |
Thomas |
PRE 284 |
Noninvasive Prenatal Screening For Copy Number Variants: Opinions and Current Use By Prenatal Genetic Counselors |
Kara |
Vitalone |
PRE 285 |
Biallelic variants in MYMK as a novel cause of recurrent cystic hygroma and early fetal hydrops in two consecutive pregnancies: Phenotypic expansion of Carey-Fineman-Ziter syndrome |
Lauren |
Westerfield |
PRE 286 |
Revisiting the Essential Informational Needs of Parents Receiving a Diagnosis of Down Syndrome |
Margaret |
Wilkes |
PRE 287 |
NGS Panel Testing in the Prenatal Diagnosis of RASopathies in Fetuses with Abnormal Ultrasound Findings |
Bradley |
Williams |
PI 288 |
Tracking and Management of Variants of Uncertain Significance in Clinics Over Time |
Elise |
Bergin |
PI 289 |
Techniques to Facilitate Communication Among Racially And Ethnically Isolated Genetic Professionals |
Austin |
Bland |
PI 290 |
Career Ladder Development: Insights and Experiences from Both Clinical and Industry Genetic Counselors |
Hayley |
Bottino |
PI 291 |
A National Sampling of Characteristics of a Genetic Counselor Career Ladder |
Hayley |
Bottino |
PI 292 |
Exploring the Integration of Adverse Childhood Experiences in Genetic Counseling Practice |
Hannah |
Brodner |
PI 293 |
GCs become established in a new position in 4 months, as indicated by decreases in documentation time |
Colleen |
Caleshu |
PI 294 |
Peer-Reviewed Outcomes and Perceptions of Genetic Counseling Student Research |
Caitlin |
Clark-Wiest |
PI 295 |
Exploring Genetic Counselors’ Perceptions and Attitudes Towards Preimplantation Genetic Testing for Aneuploidy (PGT-A) |
Danika |
Coulson |
PI 296 |
An Academic RVU for Genetic Counselors: Development of a Tool to Measure Productivity |
Sandra |
Darilek |
PI 297 |
Misinterpretation of Genetic Test Results by Healthcare Providers |
Katherine |
Donohue |
PI 298 |
An Exploration of Genetic Counselors’ Use and Application of Family Health History Tools |
Pankti |
Doshi |
PI 299 |
Bridging the Gap between Genetic Counselors and Special Education: A Survey on Genetic Counselors' Knowledge and Attitudes |
Rosetta |
Dowling |
PI 300 |
Improving Access to Potential Genetic Counseling Students through High School Counselors |
Summer |
Duffy |
PI 301 |
Genetic Counseling Job Search: Facilitators and Barriers |
Sierra |
Dyer |
PI 302 |
Does Experience Matter? An Examination of the Factors Influencing Application and Acceptance of Jobs by Genetic Counselors |
Sierra |
Dyer |
PI 303 |
Laboratory Genetic Counselors’ Motivations for Choosing this Practice Specialty: A Qualitative Investigation |
Maribeth |
Golm |
PI 304 |
Investigating the Factors That Affect Providers’ Discussion of Pre-Implantation Genetic Testing for Adult-Onset Hereditary Cancer Syndromes in Gene Positive Patients |
Ashley |
Kennes |
PI 305 |
The “Floating GCA”: Introducing a Multidisciplinary Genetic Counseling Assistant in an Academic Hospital |
Courtney E. |
Leonard |
PI 306 |
: Involvement of Genetic Counselors at State-Level Association in Pennsylvania |
Claire |
Nelson |
PI 307 |
Exploring the experience of reapplying for admission to genetic counseling programs after initial rejection |
Gabrielle |
Pomorski |
PI 308 |
INTRAPERSONAL AND DEMOGRAPHIC PREDICTORS OF COMPASSION FATIGUE IN GENETIC COUNSELORS: A MULTIPLE VARIABLE INVESTIGATION |
Jimena F |
Prado Hernandez |
PI 309 |
Defining the Roles of Laboratory Genetic Counseling Assistants and Important Factors in the Genetic Counselor – Genetic Counseling Assistant (GC-GCA) Relationship |
Jordyn |
Prell |
PI 310 |
How Genetic Counselors Remain Informed of Practice Guidelines. |
Samantha |
Sandlow |
PI 311 |
Geographical Analysis of the Distribution of Certified Genetic Counselors in the United States |
Karina |
Skov |
PI 312 |
THE CAREER ARC OF GENETIC COUNSELORS AND A CHANGING PROFESSIONAL LANDSCAPE |
Wanchun |
Smires |
PI 313 |
Outcomes of a Genetic Counseling Assistant Mentorship Program |
Elise |
Watson |
PI 314 |
Perceived Value of Genetic Counseling for Consumer-Initiated Genetic Testing |
Nori |
Williams, CGC |
PI 315 |
Life Outside Clinic: The Lived Experiences and Family Planning Decisions of Genetic Counselors Working with Pediatric Patients |
Kristen |
Wong |
PI 316 |
Diverse Career Considerations of Potential Genetic Counseling Applicants |
Rachel |
Wyatt |
NEU 317 |
Presenting Features and the Availability of Parental Testing Strongly Influence Diagnostic Rates of Multi-Gene Panels for Brain Malformation Disorders |
Sohnee |
Ahmed |
NEU 318 |
Characterization of Depressive Symptoms in Individuals with Reduced Penetrance Huntington’s Disease Allele Expansions using Enroll-HD |
Christina |
Dailey |
NEU 319 |
“IT TAKES AWAY WHAT MADE A PERSON THAT PERSON”: RECONSTRUCTING IDENTITY IN RESPONSE TO GENETIC RISK OF BEHAVIORAL VARIANT FRONTOTEMPORAL DEMENTIA |
Laynie |
Dratch |
NEU 320 |
Nuclear localization of ATXN1 in extra-cerebellar SCA1 pathology |
Hillary |
Handler |
NEU 321 |
Perceptions of Social Rejection and Fear in Individuals with Mosaic Down Syndrome |
Quinn |
Hurshman |
NEU 322 |
The ALS Genetic Access Program: Paving the Way for Genetic Testing, Counseling and Therapy for ALS |
Jennifer |
Roggenbuck |
NEU 323 |
An Investigation into the reasons behind quality of life perception in individuals with HNPP as compared to individuals with CMT1A |
Caitlin |
Walsh |
PH 324 |
Insurance Coverage Impacts the Clinical Use of Prenatal Chromosomal Aneuploidy Screening: Implications for Health Equity |
Megan |
Benoy |
PH 325 |
Estimating the need for and utilization of allogeneic hematopoietic cell transplantation (alloHCT) to treat severe combined immunodeficiency (SCID) |
Anna |
DeSalvo, MS, CGC |
PH 326 |
Patient Navigators vs. Electronic Medical Record Messaging: Genetic counseling appointment completion in an underserved population |
Amber |
Gemmell |
PH 327 |
Assessment of Cancer Risk Understanding and Motivations of Individuals Receiving Negative Screening Results in the Healthy Oregon Project |
Emily |
Guilbert |
PH 328 |
Primary Care for Rare Disease Patients: Exploring services received, healthcare providers involved, and patient satisfaction |
Catherine |
Mayo |
PH 329 |
Tower of Babel: A Qualitative Cross-Site Comparison of Provider Terminology when Discussing Universal Lynch Syndrome Screening |
Zachary |
Salvati |
RI 330 |
Attitudes About Data Sharing in Parent and Adolescent Participants in a Pediatric Genomic Research Repository |
Courtney |
Berrios |
RI 331 |
What is ‘Usual Care’ in Genetic Counseling Research? Evidence from CSER Consortium Studies |
Barbara |
Biesecker |
RI 332 |
Biobank set-up and execution: A retrospective effort analysis |
Carrie |
Blout |
RI 333 |
Developing a framework for performing genotype-phenotype analyses using a real-world data platform |
Kristina |
Cotter |
RI 334 |
The Million Veteran Program - Return Of Actionable Results (MVP-ROAR) Study: Design and Pilot Results |
Morgan |
Danowski |
RI 335 |
Variant reclassifications at the intersection of research and clinical care |
Emma |
Perez |
RI 336 |
Spatial and nonspatial barriers to Undiagnosed Diseases Network acceptance: Implications for accessing research |
Gianna |
Petrelli |
RI 337 |
Declining medically actionable genetic results: Why Mass General Brigham Biobank participants opt out of clinical result confirmation |
Janelle |
Shea, BS, BA |
UM 338 |
Work Smarter, Not Harder: Use of a Dynamic Database to Streamline Test Utilization Management |
Sarah |
Arneson |
UM 339 |
Implementation and Cost Savings of Optional Pre-authorization at a Large Pediatric Institution |
Kathleen |
Collins Ruff |
UM 340 |
Implementation of genetic carrier screening in the OB population: healthcare cost impact and recommendation adherence |
Aranza |
Gonzalez Cendejas |
UM 341 |
Current hereditary cancer reflex testing practices for Ashkenazi Jewish individuals, a large commercial laboratory’s experience |
Mary |
Hricik |
UM 342 |
Assessing the Impact of a Genetic Counseling Assistant at a Hematology Reference Laboratory |
Stefanie |
Dugan, MS, CGC |
UM 343 |
Genetic Counselors’ Involvement and Perceived Impact in the IEP and 504 School Accommodations Process |
Kaitlin |
Oconnell |
UM 344 |
Assessing The Current Landscape of National Payer Policy Regarding Genetic Counseling Services and Billing Practices |
Eric |
Tricou |
UM 345 |
Laboratory Genetic Counseling Assistant Adds Value to a Genetic Test Stewardship Program |
Claire |
Wittowski |
CAN 346 |
A Variant in the PMS2 Gene versus PMSCL pseudogene in a Patient with Prostate Cancer: Implications for Patient Counseling and Additional Testing |
Amanda |
Schott |